The University of Nebraska Medical Center is involved with an international study that challenges views on chronic obstructive pulmonary disease, COPD. Dr. Stephen Rennard is a professor of pulmonary and critical care medicine in the Department of Internal Medicine and the author of a paper published in the latest issue of the New England Journal of Medicine. His research urges health professionals and drug developers to reevaluate treatment of the illness and to get rid of thoughts the condition only gets worse.
A three year study involving 2,163 patents around the world were involved in this study on whether specific treatments can stabilize lung function or improve it. Dr. Rennard says the study suggests those with moderate COPD lose lung function more quickly than those with a severe condition and he would like to see a change in the focus of treatment. COPD kills more than 120-thousand Americans each year and can cause serious, long-term disability. Symptoms include shortness of breath, cough and production of phlegm.